MGH ovarian cancer researchers are hoping to start a clinical trial later this year using losartan, a well known anti-hypertensive, to examine how it can enhance the anti-tumor effects of chemotherapy.
Researchers studying pancreatic cancer, have found that losartan reduces the extracellular matrix around tumor cells. This is significant because the matrix increases the density around tumor cells preventing drugs from penetrating the tumor.
To find out more about this research, follow this link to MGH
In October 2012, a dream was realized for two dynamic ovarian cancer survivors: Anne Tonachel and Robin Bray. Their dream was to provide a restorative retreat for other ovarian cancer survivors in the northeast. When the amazing Kennedy family of Camp Kieve and The Kennedy Learning Center provided the retreat space (in honor of a family member with ovarian cancer), this restorative retreat was born.
No comments:
Post a Comment